Data sets featuring personal identifiers -including studies evaluating genomes of thousands of people to characterize medically relevant genetic variants -are but one example. Such data may be critical to developing new drugs or diagnostic tools, but cannot be shared openly; even anonymized personal data can be subject to re-identification, and it has been a long-standing practice for agencies and journals to acknowledge the value of data-privacy adjustments. The principles of careful data management, as they inform medicine, are just as applicable to data regarding environmental influences on public health. Discounting evidence from the decision-making process on the basis that some data are confidential runs counter to the EPA stated mission "to reduce environmental risks … based on the best available scientific information" (see go.nature. com/2kqheny).
We are also concerned about how the agency plans to consider options related to existing regulations. Even if a new standard is not applied retroactively, the standard could apply when a regulation is updated; thus, foundational science from years past -research on air quality and asthma, for example, or water quality and human health -could be deemed by the EPA to be insufficient for informing our most significant public-health issues. That would be a catastrophe.
We urge the EPA to continue to adopt an approach that ensures the data used in decisionmaking are the best available, which will at times require consideration of peer-reviewed com/2kmtd7g), we have become more concerned in response to recent media coverage and a 13 November hearing on the role of science in decisionmaking at the EPA. These events suggest that the proposed rule is now moving towards implementation; whether it includes amendments sufficient to address the concerns raised by us and many others remains a question.
Our previous statement on the proposed rule, authored and published by the editorsin-chief of five major scientific journals in May 2018, reflected alarm that the proposal's push for 'transparency' would be used as a mechanism for suppressing the use of relevant scientific evidence in policy-making, including public-health regulations. After the public comment period for the proposed rule closed, the EPA reported more than 590,000 comments from individuals and scientific, medical and legal groups, many of which articulated similar concerns (see go.nature. com/2jfxhhn).
As leaders of peer-reviewed journals, we support open sharing of research data, but we also recognize the validity of scientific studies that, for confidentiality reasons, cannot indiscriminately share absolutely all data.
Boost glacier monitoring
Glacier-mass changes are a reliable indicator of climate change. On behalf of the worldwide network of glacier observers, we urge parties to the United Nations Framework Convention on Climate Change to boost international cooperation in monitoring these changes, and to include the results in the Paris agreement's global stocktake.
Since 1960, glaciers have lost more than 9,000 gigatonnes of ice worldwide -the equivalent of a 20-metre-thick layer with the area of Spain. This melting alone -as distinct from that of the Greenland and Antarctic ice sheets -has raised global sea level by almost 3 centimetres, contributing 25-30% of the total rise (M. Zemp et al. Nature 568, 382-386; 2019) .
The present rate of melting is unprecedented. Several mountain ranges are likely to lose most of their glaciers this century. And we face the loss of almost all glaciers by 2300 (B. Marzeion et al. Cryosph. 6, 1295 -1322 2012) .
Glacier shrinkage will severely affect freshwater availability and increase the risk of local geohazards. Global sea-level rise will result in the displacement of millions of people in coastal regions and in the loss of life, livelihoods and culturalheritage sites.
The systematic monitoring of glaciers has been internationally coordinated for 125 years. Continuing to do so will document progress in limiting climate change for current and future generations.
